Physician profile
Robin M Mikel
NPI 1740481977
$1,231.82
in general payments reported to CMS, 2019-2025
21 companies · $189 in 2025
The $189 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $97.06 · 2021: $82.42 · 2022: $218 · 2023: $192 · 2024: $231 · 2025: $189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $612.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $611.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $336.86 | 2019-2025 | |
| Organon LLC | $139.56 | 2022-2025 | Nexplanon |
| Astellas Pharma US INC | $137.66 | 2023-2025 | Veozah |
| Pfizer INC. | $86.41 | 2022-2025 | |
| Hologic Sales and Service, LLC | $70.57 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Merck Sharp & Dohme LLC | $66.70 | 2019-2023 | Gardasil 9 |
| Bayer Healthcare Pharmaceuticals INC. | $56.14 | 2019-2020 | |
| Sage Therapeutics, LLC | $54.32 | 2020-2024 | |
| Coopersurgical, INC. | $36.36 | 2019-2023 | Advincula Delineator Uterine Manipulator |
| Avion Pharmaceuticals | $26.71 | 2019-2021 | |
| Axonics, INC. | $26.43 | 2023 | Bulkamid |
| Octapharma USA, INC. | $24.82 | 2025 | Fibryga |
| Agile Therapeutics, INC. | $23.99 | 2024 | Twirla |
| Roche Diagnostics Corporation | $23.03 | 2019 | |
| Alexion Pharmaceuticals, INC. | $20.36 | 2023 | Ultomiris |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $19.99 | 2024 | Intrarosa |
| Exeltis, USA INC. | $18.95 | 2022 | |
| Davol INC. | $18.60 | 2023 | Channel Drain |
| Minerva Surgical, INC | $17.89 | 2025 | |
| Therapeuticsmd, INC. | $14.92 | 2021 | |
| Allergan, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robin Mikel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.